Alex Fraser, Patient Access Lead at GROW Pharma, speaks to Eric Bystrom, CEO of Cellen Therapeutics, an independent UK based company run by NHS consultants who are on a mission to break down the barriers to accessing medical cannabis.
Discussing a range of topics including
- Issues with patient access
- Developing bespoke medicines|
- Nuances of developing cannabis medicines for the UK
- Project Twenty21?
- Real world evidence vs RCT’s
And much much more.
Find our more about Cellen at www.cellenhealth.com
Follow Eric on www.twitter.com/e_bystrom
Follow Alex on www.twitter.com/AlexFraserCanna
-----------------------------------------------------------------------------------------------------
Grow Conversations is your window into the world of medical cannabis.
Brought to you by Grow Pharma - Unlocking the Medical Potential of Cannabis
Grow Pharma's Links: https://linktr.ee/grow_pharma
Grow Group's Links: https://growgroup.komi.io/
Follow Alex: https://linktr.ee/alexfrasercan...
Alex Fraser, Patient Access Lead at GROW Pharma, speaks to Eric Bystrom, CEO of Cellen Therapeutics, an independent UK based company run by NHS consultants who are on a mission to break down the barriers to accessing medical cannabis.
Discussing a range of topics including
- Issues with patient access
- Developing bespoke medicines|
- Nuances of developing cannabis medicines for the UK
- Project Twenty21?
- Real world evidence vs RCT’s
And much much more.
Find our more about Cellen at www.cellenhealth.com
Follow Eric on www.twitter.com/e_bystrom
Follow Alex on www.twitter.com/AlexFraserCanna
-----------------------------------------------------------------------------------------------------
Grow Conversations is your window into the world of medical cannabis.
Brought to you by Grow Pharma - Unlocking the Medical Potential of Cannabis
Grow Pharma's Links: https://linktr.ee/grow_pharma
Grow Group's Links: https://growgroup.komi.io/
Follow Alex: https://linktr.ee/alexfrasercan...